These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22015691)

  • 41. Lipids as targets for novel anti-inflammatory therapies.
    Huwiler A; Pfeilschifter J
    Pharmacol Ther; 2009 Oct; 124(1):96-112. PubMed ID: 19576246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammation and immune regulation by 12/15-lipoxygenases.
    Kühn H; O'Donnell VB
    Prog Lipid Res; 2006 Jul; 45(4):334-56. PubMed ID: 16678271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoxins and resolvins in inflammatory bowel disease.
    Weylandt KH; Kang JX; Wiedenmann B; Baumgart DC
    Inflamm Bowel Dis; 2007 Jun; 13(6):797-9. PubMed ID: 17262807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.
    Das UN
    Lipids Health Dis; 2016 Jan; 15():11. PubMed ID: 26762544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.
    Krishnamoorthy N; Abdulnour RE; Walker KH; Engstrom BD; Levy BD
    Physiol Rev; 2018 Jul; 98(3):1335-1370. PubMed ID: 29717929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current and Future Directions for Targeting Lipoxin A4 in Alzheimer's Disease.
    Dias IHK; Griffiths HR
    J Alzheimers Dis; 2021; 81(1):87-90. PubMed ID: 33720904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of proresolving and inflammatory lipid mediators in human psoriasis.
    Sorokin AV; Norris PC; English JT; Dey AK; Chaturvedi A; Baumer Y; Silverman J; Playford MP; Serhan CN; Mehta NN
    J Clin Lipidol; 2018; 12(4):1047-1060. PubMed ID: 29730187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resolution of adipose tissue inflammation.
    González-Périz A; Clària J
    ScientificWorldJournal; 2010 May; 10():832-56. PubMed ID: 20454765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proresolution mediators and receptors: novel drug targets for enhancing pharmacological armamentarium against periodontal inflammation.
    Grover V; Malhotra R; Kapoor A; Singh J; Sachdeva S
    Infect Disord Drug Targets; 2013 Feb; 13(1):75-84. PubMed ID: 23713671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Complexity of Omega-3 Fatty Acid Modulation of Signaling Pathways Related to Pancreatic Cancer.
    Torres C; Diaz AM; Principe DR; Grippo PJ
    Curr Med Chem; 2018; 25(22):2608-2623. PubMed ID: 28618995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases.
    Calviello G; Su HM; Weylandt KH; Fasano E; Serini S; Cittadini A
    Biomed Res Int; 2013; 2013():743171. PubMed ID: 23691510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiation resistance, invasiveness and metastasis are inflammatory events that could be suppressed by lipoxin A4.
    Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2012; 86(1-2):3-11. PubMed ID: 22014542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.
    Fredman G; Tabas I
    Am J Pathol; 2017 Jun; 187(6):1211-1221. PubMed ID: 28527709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediator lipidomics in acute inflammation and resolution.
    Arita M
    J Biochem; 2012 Oct; 152(4):313-9. PubMed ID: 22923733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pro-resolving lipid mediators: Agents of anti-ageing?
    Doyle R; Sadlier DM; Godson C
    Semin Immunol; 2018 Dec; 40():36-48. PubMed ID: 30293857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipoxins as biomarkers of lupus and other inflammatory conditions.
    Das UN
    Lipids Health Dis; 2011 May; 10():76. PubMed ID: 21569625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs.
    Murray M; Hraiki A; Bebawy M; Pazderka C; Rawling T
    Pharmacol Ther; 2015 Jun; 150():109-28. PubMed ID: 25603423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing.
    Norling LV; Spite M; Yang R; Flower RJ; Perretti M; Serhan CN
    J Immunol; 2011 May; 186(10):5543-7. PubMed ID: 21460209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipoxins and annexin-1: resolution of inflammation and regulation of phagocytosis of apoptotic cells.
    Scannell M; Maderna P
    ScientificWorldJournal; 2006 Dec; 6():1555-73. PubMed ID: 17160341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.